EQUITY RESEARCH MEMO

Plas-Tech Engineering

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)55/100

Plas-Tech Engineering is a privately held, US-based contract manufacturer specializing in medical devices and drug delivery systems. Founded in 1998 and headquartered in Coventry, the company operates an ISO 13485 certified, cGMP-compliant facility with clean room capabilities, enabling high-precision manufacturing for complex projects. Leveraging decades of experience, Plas-Tech serves clients requiring difficult-to-manufacture products across the medical and pharmaceutical sectors. As a established player in a growing market driven by demand for specialized manufacturing, the company is well-positioned to capitalize on outsourcing trends. However, limited public information and absence of recent funding or expansion announcements constrain visibility into near-term performance.

Upcoming Catalysts (preview)

  • Q4 2026New long-term contract with a major pharmaceutical company60% success
  • Q2 2027Capacity expansion or facility upgrade announcement40% success
  • Q1 2027Certification or regulatory milestone (e.g., FDA approval for a client product)50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)